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Synaptic a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)
receptors are essential mediators of neurotransmission in the central ner-
vous system. Shisa9/cysteine-knot AMPAR modulating protein 44
(CKAMP44) is a transmembrane protein recently found to be present in
AMPA receptor-associated protein complexes. Here, we show that the
cytosolic tail of Shisa9/CKAMP44 interacts with multiple scaffold proteins
that are important for regulating synaptic plasticity in central neurons. We
focussed on the interaction with the scaffold protein PICK1, which facili-
tates the formation of a tripartite complex with the protein kinase C
(PKC) and thereby regulates phosphorylation of Shisa9/CKAMP44
C-terminal residues. This work has implications for our understanding of
how PICK1 modulates AMPAR-mediated transmission and plasticity and
also highlights a novel function of PKC.
The ionotropic glutamate receptors are of particular
importance for fast synaptic transmission in the central
nervous system. Among these ligand-gated receptors,
the a-amino-3-hydroxyl-5-methyl-4-isoxazole-propio-
nate (AMPA) receptors are especially important for reg-
ulating changes in synaptic strength; elucidating the
mechanisms by which these receptors are regulated is
therefore critical for our molecular understanding of
information storage in the brain. Recent studies indicate
that they are found in complex with additional trans-
membrane proteins that modulate receptor function,
including the Shisa/cysteine-knot AMPAR modulating
protein (CKAMP) family of proteins, among others.
Shisa/CKAMP proteins were originally described
for their role in head formation [1] and were named
Shisa after a form of sculpture with a large head
(similar to the Egyptian Sphinx) that is found in
southern Japan. The first study on Shisa family tran-
script expression in the mouse brain focussed on the
transcript for Shisa2; since then, high-throughput
in situ analyses have confirmed that several of the
Shisa transcripts, including. Shisa5, 6, 7 and 9, exhibit
high expression in the brain, and each one has
restricted expression in a subset of CNS neurons (see
Allen Mouse Brain Atlas: http://mouse.brain-map.org)
[2], suggesting that these proteins may be involved in
specific neuronal functions. Indeed, more recent studies
indicated that Shisa9 is present in AMPA receptor
complexes and that its presence there regulates synap-
tic transmission by modulating AMPA receptor chan-
nel properties [3]. In addition, it has now been shown
that not only Shisa9 but also Shisa6, 7 and 8 are
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capable of influencing receptor function [4,5]. In the
light of these new studies, this subgroup of Shisa pro-
teins is now also referred to as the CKAMP family,
based on their common ability to modulate AMPAR
synaptic transmission. Another property that these
CKAMP proteins share is the presence of a conserved
C-terminal sequence typical for proteins that have
been shown to bind a postsynaptic density protein 95
(PSD-95) Dlg1 and ZO-1 (PDZ) domain, the 80–90
AA structurally conserved motif originally identified
for its presence in PSD-95, Dlg1 and ZO-1 proteins.
Numerous cytosolic proteins at synapses harbour
PDZ domains and are capable of interacting directly
with the cytoplasmic tails of transmembrane receptors,
and it has been shown that such PDZ–ligand interac-
tions are important for the trafficking of AMPA recep-
tors to and from the cell surface [6]. Notably, it has
become clear in recent years that direct interactions
between PDZ domain proteins and AMPA receptor
subunits themselves are not exclusively responsible for
this regulation of AMPAR surface expression. Cumu-
lative data from several groups suggest that transmem-
brane AMPAR-interacting proteins are essential for
this function (for review, see [7]). As several of these
proteins also influence the gating properties of isolated
AMPA receptors, they are often referred to collectively
as AMPA receptor auxiliary proteins (for recent
reviews, see [7,8]). Among these transmembrane
AMPAR auxiliary proteins, the transmembrane
AMPAR regulatory protein (TARP) family has been
studied in most depth: it is well established that
TARPs are involved in the modulation of AMPAR
desensitisation and also play a critical role in AMPAR
trafficking to the surface. Importantly, the latter func-
tion of TARPs clearly relies on the C-terminal cytoso-
lic region that binds to PDZ domains of specific
synaptic scaffold molecules [9–11], illustrating that the
cytosolic C-terminal tail of AMPAR auxiliary proteins
can play a decisive role in AMPA receptor function
via this mechanism.
It has further been established that phosphorylation
of the C-terminal regions of ionotropic glutamate
receptor subunits themselves, and also the TARP fam-
ily of auxiliary proteins, can dramatically influence
receptor function, presumably by influencing interac-
tions between AMPAR complexes and cytosolic pro-
teins or specific cellular components. It has been
shown, for example, that serine residues within the C-
terminal cytosolic region of AMPAR subunits GluA1
and GluA2 are phosphorylated [by, e.g., protein kinase
A (PKA), PKC and Ca2+/calmodulin-dependent pro-
tein kinase II (CaMKII)] and that the phosphorylation
status influences channel conductance and opening
probability (for recent review, see [12]). Also relevant
is the fact that modulating the phosphorylation status
of the TARPɣ2 C terminus can dramatically influence
its localisation and function [13–15].
In this study, we focus on Shisa9/cysteine-knot
AMPAR modulating protein 44 (CKAMP44), a small
protein with only one transmembrane domain (TM). It
was initially proposed that its effects on AMPAR-
mediated transmission are mediated by a set of six
N-terminal extracellular cysteines, as this region resem-
bles that of the snail conotoxin (Cys-ikot-ikot) that
disrupts AMPAR desensitisation [3]. It has since been
shown that the C-terminal intracellular domain is also
functionally important. Like the TARPs, Shisa9/
CKAMP44 harbours a long C-terminal cytosolic tail
that is presumably a target for both interactions with
cytosolic scaffolds and regulation by associated
kinases. Given that Shisa9/CKAMP44 binds to
AMPARs and modulates specific functions at the
membrane, we considered it highly relevant to explore
how this protein is regulated by other protein–protein
interactions. In this study, we have screened for and
identified cytoplasmic interaction partners of Shisa9/
CKAMP44, including the synaptic scaffold molecule
protein interacting with C kinase 1 (PICK1). More
importantly, we demonstrate that this interaction facil-
itates regulation of Shisa9/CKAMP44 by PKC, which
highlights a novel function of PKC in neurons that
will significantly influence future investigations into
PICK1 and PKC-mediated effects on AMPAR compo-
sition and function.
Results
Shisa9/CKAMP44 interacts with several synapse-
associated PDZ-containing scaffold proteins
In order to determine putative cytosolic binding part-
ners of Shisa9/CKAMP44, we used this region of the
protein as bait in a yeast two-hybrid (Y2H) assay and
identified several putative interaction partners (sum-
marised in Fig. 1A). Within this list were several scaf-
fold proteins harbouring PDZ domains [e.g. PICK1,
DLG1/SAP97, DLG2/PSD-93, DLG3/synapse-asso-
ciated protein 102 (SAP102), DLG4/PSD-95, MPP5,
membrane-associated guanylate kinase inverted 1
(MAGI1), MAGI3, LNX1, LNX2 and HTRA1], sug-
gesting that the C-terminal region of Shisa9/CKAMP44
is indeed a PDZ ligand, as predicted by sequence analy-
sis [3] and likewise observed in more recent work
[5,16,17]. We validated an interaction of the synapse-
associated PDZ domain proteins PICK1, MAGI1,
PSD-95 and SAP102 with the full-length Shisa9/
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CKAMP44 by coimmunoprecipitation (Fig. 1B–E), and
confirmed that Shisa9/CKAMP44 localises to synaptic
sites in primary neurons (Fig. 1F–H). Further experi-
ments indicated that the interaction with membrane-
associated guanylate kinase (MAGUK) scaffolds relies
exclusively on the C-terminal PDZ-binding motif of
Shisa9/CKAMP44 and the two most N-terminal
MAGUK PDZ domains (see Fig. S1), highlighting a
clear binding specificity for PDZ domains 1 and 2.
The Shisa9/CKAMP44 interaction with PICK1
facilitates Shisa9/CKAMP44 phosphorylation by
PKC
In the following experiments, we focussed on the inter-
action of Shisa9/CKAMP44 with the protein PICK1,
which has been shown previously to bind directly with
AMPA receptor subunit C-terminal tails in a ligand–
PDZ domain interaction [18,19]. Unexpectedly, we
observed that the Shisa9/CKAMP44-PICK1 interac-
tion is not exclusively dependent on the PDZ-binding
motif in Shisa9/CKAMP44, which differs from the
interaction with PSD-95 and SAP102 (Fig. S1) as
demonstrated in coimmunoprecipitation experiments
(Fig. 2B). To further narrow down the interaction
region, we deleted a more proximal region of the
cytosolic tail and observed an even further reduced
interaction of PICK1 with Shisa9/CKAMP44 (Fig. 2B;
for schematic diagram of deletion constructs used, see
Fig. 2A). This proximal region of the cytoplasmic tail
of Shisa9/CKAMP44 contains an amino acid (AA)
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Fig. 1. Novel interaction partners of Shisa9/CKAMP44 and localisation at synaptic sites. (A) Results of a Y2H screen with Shisa9/CKAMP44
(mouse, AAs 171–424, cytoplasmic tail), as an N-LexA-Shisa9-C fusion, performed on a mouse brain cDNA library. (B–E) Confirmation of
selected interactions, namely those with PICK1, MAGI1, PSD-95 and SAP102: coimmunoprecipitation experiments (COS-7) of
overexpressed FLAG- or MYC-tagged full-length Shisa9/CKAMP44 (FLAG/MYC-CKAMP44-FL) together with MYC-PICK1 (B), FLAG-MAGI1
(C), FLAG-PSD-95 (D) or FLAG-SAP102 (E). Proteins were immunoprecipitated with the antibodies indicated, that is with commercially
available FLAG or MYC antibodies, or with mIgG as a negative control, and subsequently detected by WB. Input (lysate) control is shown
on the left (longer exposures in C/D/E). (F) Overlay image of typical primary hippocampal neuron (DIV21) expressing FLAG-CKAMP44-FL
(cyan); neurons are costained for MAP2 (magenta); high-resolution insert shown below. Scale bar 10 lm. (G) FLAG-CKAMP44-FL (cyan, left)
colocalises with endogenous PSD-95 (magenta, middle), a postsynaptic protein. Overlay is shown on the right. Scale bar 2 lm. (H)
Costaining of FLAG-CKAMP44-FL (cyan, left) with endogenous presynaptic vGlut1 (magenta, middle) shows adjacent signals. Overlay is
shown on the right. Scale bar 2 lm.
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also across Shisa/CKAMP family proteins [4] and has
been shown to bind GluA1 in co-immunoprecipitation
(IP) experiments [17]. In this context, it is interesting
that this region also has an influence on PICK1-
Shisa9/CKAMP44 binding.
These data led us to hypothesise that the binding
between PICK1 and Shisa9/CKAMP44 is an impor-
tant, high-affinity interaction that could be subject to
temporal or signal-dependent regulation. PICK1 was
named for its role as an interaction partner for the
protein kinase PKC [20,21]. We therefore asked
whether Shisa9/CKAMP44 might be a target of PKC-
mediated phosphorylation. Using the Phos-tag system,
we demonstrated that wild-type Shisa9/CKAMP44 is
indeed modified following expression in heterologous
cells and that the observed mobility shift was inhibited
following phosphatase treatment (Fig. 2C), confirming
that we indeed observed a phosphorylation-dependent
shift. In addition, phosphorylation could be modulated
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Fig. 2. Shisa9/CKAMP44 interacts with PICK1 and is phosphorylated by PKCa. (A) Schematic overview of Shisa9/CKAMP44 constructs used
in this study (including the location of the respective tag): in CKAMP44-FL (full length), the tag is C-terminal to the signal peptide in the
extracellular domain (TM, yellow). Constructs with only the cytoplasmic tail of Shisa9/CKAMP44 are N-terminally tagged (with either EGFP
or GST). PDZ ligand sequences are shown in red and are deleted in constructs labelled with DC (PDZ-binding-deficient variant). A conserved
region of Shisa9/CKAMP44 (blue; N-terminal region of the cytoplasmic tail) is deleted in the construct CKAMP44-DNDC. Constructs are
drawn to scale. (B) Comparative coimmunoprecipitation experiments of PICK1 (FLAG-PICK1) with Shisa9/CKAMP44 C-terminal variants
EGFP-CKAMP44, DC, or DNDC). Proteins were precipitated using GFP antibody or mIgG (negative control) and detected using the
antibodies indicated. Inputs are shown on the left. (C) Full-length Shisa9/CKAMP44 (FLAG-CKAMP44-FL), expressed in COS-7 cells, is
phosphorylated following induction by PMA (1 lM, 30 min). Phosphorylated proteins (indicated) are separated from nonphosphorylated
proteins (indicated) via Phos-tag-SDS/PAGE and observed via WB; phosphatase treatment with alkaline phosphatase is used as a negative
control, thereby highlighting the phosphorylation dependence of the mobility shift. (D) Phosphorylation of Shisa9/CKAMP44 (FLAG-
CKAMP44-FL) is induced with PMA and inhibited by application of the PKC inhibitor GF109203X in COS-7 cells. Again phosphorylated
proteins are observable via Phos-tag-SDS/PAGE. PKC inhibitor concentrations are indicated above. (E) An in vitro PKCa kinase assay
followed by Phos-tag SDS/PAGE analysis highlights a PKCa-dependent mobility shift of the phosphorylated substrate GST-CKAMP44 (top
panel, Phos-tag SDS/PAGE). Presence of PKCa and kinase substrate present in the same samples is shown below (lower panel, standard
Laemmli SDS/PAGE and WB; antibodies indicated).
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activates PKC signal cascades. Moreover, while PMA
treatment amplified the relative phospho-Shisa9/
CKAMP44 signals, PKC inhibitors, including
GF109203X, reduced total phosphorylation of Shisa9/
CKAMP44 (Fig. 2C,D) in this system, supporting the
idea that Shisa9/CKAMP44 can be regulated by PKC.
Importantly, we also observe these PKC-dependent
changes in the phosphorylation of Shisa9/CKAMP44
in a neuronal environment (see Fig. 3), and we demon-
strated that Shisa9/CKAMP44 is indeed a direct PKC
target using purified PKCa with the GST-tagged
Shisa9/CKAMP44 cytosolic tail as a substrate in an
in vitro kinase assay (Fig. 2E).
Shisa9/CKAMP44 forms a complex with PICK1
and PKC that is regulated by activation of PKC
signalling cascades in neurons
We next confirmed that Shisa9/CKAMP44, PICK1
and PKC indeed form a tripartite complex in coim-
munoprecipitation experiments (Fig. S2). Interestingly,
activated PKC binds more effectively than inactive
PKC to the PICK1-Shisa9/CKAMP44 complex
(Fig. 3A; co-IP with or without PMA stimulation),
which is in line with the dramatic phosphorylation of
Shisa9/CKAMP44 observed following PMA
stimulation in the presence of both PICK1 and wild-
type PKCa (Fig. 3B; lane 3 of Phos-tag panel). A sim-
ilar phospho-dependent mobility shift of Shisa9/
CKAMP44 in response to PKC activation was
observed in primary hippocampal neurons (Fig. 3C;
compare lanes 3 and 4 of the Phos-tag panel), confirm-
ing the importance of endogenous PKC in the regula-
tion of this AMPAR auxiliary protein at synapses. In
line with these data, we observe a strong increase in
colocalisation of neuronal PICK1 with synaptic
Shisa9/CKAMP44 following activation of endogenous
PKC with PMA (see representative images in Fig. 3D).
Digital analysis of overlapping signals (synaptic
FLAG-CKAMP44-FL with endogenous PICK1
puncta) indicated approximately a 1.4-fold increase in
colocalisation in response to treatment with PMA
(1.388  0.086; see data points and quantification of
observations in the Fig. 3D bar diagram).
These data support a model proposed earlier [19],
in which activation of PKC stabilises the interac-
tion between PKCa and PICK1. We further
demonstrate here that PKC activation promotes
localisation of PICK1 towards Shisa9/CKAMP44 at
synaptic sites, which enables an inducible and
dynamic PKC-mediated regulation of the Shisa9/
CKAMP44 C terminus. These novel ideas are sum-
marised in Fig. 4.
Discussion
In this study, we have explored the molecular interac-
tions mediated by the cytosolic C-terminal region of
the CNS-expressed Shisa9/CKAMP44 protein. We
have identified several Shisa9/CKAMP44 binding pro-
teins, including several scaffold molecules that play an
established role in the regulation of cell–cell communi-
cation, for example PICK1 and the MAGUK family
members PSD-95, SAP102 and MAGI1. In addition to
the synaptic MAGUK proteins (PDZ-dependent inter-
action), the scaffold molecule PICK1 exhibited strong
binding to the cytosolic region of the AMPAR auxil-
iary protein Shisa9/CKAMP44.
Protein interacting with C kinase 1 and protein
kinase C (PKC) – as their names indicate – have an
established biochemical connection, and several studies
have confirmed that PICK1 cooperates with PKC to
execute various regulatory functions in neurons [22–
25]. Moreover, a role for both PICK1 and PKC in the
regulation of AMPAR-mediated plasticity has been
explored [19,26–28]. In the context of these studies,
our data highlighting a strong interaction between
PICK1 and the AMPAR receptor auxiliary protein
Shisa9/CKAMP44 and the subsequent discovery that
this protein is a novel PKC target, are of interest. Our
observation that the overlapping subcellular localisa-
tion of PICK1 and Shisa9/CKAMP44 in neurons is
dynamically regulated by activation of PKC signalling
cascades supports the idea that the interaction between
these two proteins may be a target of finely tuned tem-
poral or activity-dependent regulation by intracellular
signals. Further supporting this idea, we found that
the formation of a Shisa9/CKAMP44-PICK1-PKC
complex in response to PKC activation leads to
changes in the phosphorylation status of Shisa9/
CKAMP44 in primary neurons.
To date, there have been relatively few investigations
into the function of Shisa9/CKAMP44, but it has been
demonstrated that the N-terminal extracellular domain
of Shisa9/CKAMP44 is important for regulating
AMPAR desensitisation kinetics [3,17]. In the context
of our data, investigations into Shisa9/CKAMP44-
mediated modulation of AMPAR trafficking to the
surface, which have so far yielded diverse results, are
of particular interest. In the hippocampal CA1 region,
Shisa9/CKAMP44-deficient neurons did not exhibit a
reduction in synaptic AMPARs [3]; however, in den-
tate gyrus granule cells, where endogenous Shisa9/
CKAMP44 is expressed at higher levels, studies on
KO animal tissue suggest that the trafficking of
AMPARs to the synaptic membrane involves both
TARP and CKAMP auxiliary proteins [17]. It has
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Fig. 3. Shisa9/CKAMP44-PICK1 complex formation and regulation by active PKC in neurons. (A) PKC activation status influences CKAMP44/
PICK1/PKCa complex formation: coimmunoprecipitation experiments following expression of Shisa9/CKAMP44 (FLAG-CKAMP44-FL), PICK1
(MYC-PICK1) and PKCa (EGFP-PKCa-WT) in COS-7 cells indicate that the three proteins form a complex. After pull-down FLAG-CKAMP44-
FL, coprecipitated proteins are detected by WB, as indicated. mIgG serve as a negative pull-down control. Comparison (with or without
PMA activation, 1 lM, 30 min) indicates that EGFP-PKCa association with FLAG-CKAMP44-FL/MYC-PICK1 protein complex is modulated by
PKC activation status. (B) Phosphorylation of overexpressed Shisa9/CKAMP44 (FLAG-CKAMP44-FL) in COS-7 cells in the presence of either
wild-type or kinase-dead PKCa (EGFP-PKCa-WT and EGFP-PKCa-DN; compare lanes 3 and 4) with or without PICK1 (MYC-PICK1; compare
lanes 3 and 7) is shown (top panel; Phos-tag: phosphorylated proteins observed by mobility shift). PKC was activated by PMA (1 lM,
30 min); controls for relevant protein levels (actin: loading control) are shown below (Laemmli SDS/PAGE and WB). Antibodies used are
indicated on the right. (C) In primary hippocampal neurons, activation of PKC by PMA (0.2 lM, 15 min) likewise affects Shisa9/CKAMP44
phosphorylation status (compare lanes 3 and 4 in the Phos-tag blot, left panel). Shisa9/CKAMP44 proteins were observed by WB following
viral transduction of FLAG-CKAMP44-FL, with or without activation by PMA. Neurons were harvested at DIV22; on the right, control levels
of related proteins are observed via SDS/PAGE. (D) Overlapping localisation of Shisa9/CKAMP44 and PICK1 in primary hippocampal neurons
after activation of PKC: neurons were infected (DIV 10–15) with virus expressing Shisa9/CKAMP44 (FLAG-CKAMP44-FL) and fixed at DIV
20–24 without a treatment (upper panel) or after activation of PKC by PMA (0.2 lM, 15 min; lower panel). Immunofluorescence with a FLAG
antibody (cyan), an antibody to endogenous PICK1 (magenta) and an antibody to endogenous MAP2 (blue) is shown. Shisa9/CKAMP44–
PICK1 overlapping puncta are indicated. Merged images are shown on the right. Scale bar 5 lm. The colocalisation of FLAG-CKAMP44-FL
and endogenous PICK1 in rat hippocampal neurons was quantified with the Puncta Analyzer (IMAGEJ plugin) in dendritic segments of FLAG-
CKAMP44-FL-infected neurons (untreated: n = 49 neurons from N = 4 cultures; PMA treated: n = 48 neurons from N = 4 cultures) and
normalised to the mean of untreated condition. The colocalisation increased significantly after PMA treatment (0.2 lM PMA for 15 min) by
the factor of 1.388  0.086 (*** P = 0.0008, two-tailed Mann–Whitney U-test, U = 716.5) compared to untreated neurons (1.0  0.074).
Data are represented as mean  SEM.
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been shown clearly that this function of TARP family
auxiliary proteins relies on the cytosolic tail [9–11]; it
is therefore plausible that CKAMP family members
likewise participate in this process via intracellular
molecular mechanisms.
Our observations that the Shisa9/CKAMP44 intra-
cellular domain is a target of phospho-regulation and
interacts differentially with certain scaffold proteins
suggest that there may be parallels between how
TARPs and CKAMP family proteins influence recep-
tor trafficking. It has been shown that phosphoryla-
tion-dependent interactions of TARPs can regulate
synaptic content of both TARPs and AMPAR sub-
units: the phosphorylation status of the TARPɣ2 C
terminus influences its association with the membrane
lipid bilayer [15] and also affects its ability to interact
with PSD-95 [13,14]; these changes have implications
for AMPAR-mediated synaptic transmission. It has
also been shown that – in addition to the most C-
terminal region responsible for interacting with synap-
tic MAGUKS – other cytosolic regions of TARPs can
influence receptor trafficking [29]. In addition, the
interaction between TARPɣ2 and the intracellular scaf-
fold neuronal protein interacting specifically with Tc10
(nPIST; also known as GOPC/CAL), a Golgi-enriched
protein [30,31], can modulate the synaptic targeting of
AMPAR complexes [32]. In this case, it is not the C-
terminal PDZ-binding region of TARPɣ2 that is
responsible for the function but a more proximal
cytosolic region close to the TM. These authors pro-
pose a mechanism that involves – early on in the secre-
tory process – a PDZ-independent interaction between
TARPɣ2 and nPIST, which is followed by a PDZ
domain-mediated interaction with PSD-95 that ensures
synaptic localisation. Both of these interactions are
important for the function of TARPs as mediators of
AMPAR trafficking, and it is plausible that a similar
model applies to Shisa9/CKAMP44, which is able to
bind PICK1 and also PSD-95-family synaptic
MAGUKs.
Although Shisa9/CKAMP44 clearly binds to PICK1
via its PDZ-binding motif, we demonstrate that at
least one additional region, namely the N-terminal
region of its intracellular domain, which is also impor-
tant for its effects on AMPAR modulation [17], is also
involved in binding to this scaffold protein. This leads
to the possibility that PICK1 and GluA1 might com-
pete for this binding region of Shisa9/CKAMP44. An
additional possibility is that these interactions are tem-
porally and/or spatially separated; for example, a brief
interaction between Shisa9/CKAMP44 and PICK1
during early trafficking could be followed by PSD-95-
guided synaptic localisation and subsequent functional
interaction with AMPAR subunits.
Importantly, our observation that there are dramatic
effects on the phospho-regulation of Shisa9/
CKAMP44 specifically when it is in a complex with
PICK1 and PKC suggests that formation of this tri-
partite complex is important. The fact that the com-
plex can be dynamically regulated suggests that it may
have a transitory role, perhaps comparable to that
proposed for the TARPɣ2/nPIST interaction, which is
relevant at specific time points in the secretion and
trafficking of receptor complexes en route to the mem-
brane. Indeed, numerous investigations illustrate a role
for PICK1 in both basal (e.g. see [27,33]) and activity-
dependent receptor trafficking (e.g. see [34–37]; for
review, see [38]). It is possible that the Shisa9/
CKAMP44-PICK1 interaction and subsequent PKC-
mediated Shisa9/CKAMP44 phosphorylation that we
observe might influence early phases of AMPAR traf-
ficking in a subset of excitatory neurons. Interestingly,
a role for PICK1 in the export of AMPA receptors
from the endoplasmic reticulum (ER) has recently
been reported [39], and PKC-mediated phosphoryla-
tion of other ionotropic glutamate receptor subunits
participates in the regulation of their export from the
ER [40–42]. In addition, it has been shown that the
interaction between PICK1 and active PKCa is tran-
sient, and primarily important for initial targeting of
PICK1 to the membrane [43], where the transition of
assembled AMPAR complexes to other membrane-
associated PDZ domain scaffolds could take place.
Moreover, there is evidence that trans-Golgi network-















Fig. 4. A model illustrating the Shisa9/CKAMP44–PICK1-PKCa
protein complex. PICK1 can dimerise and is likely able to bind
Shisa9/CKAMP44 and PKCa at the same time, thereby enabling
PKCa-mediated phosphorylation of Shisa9/CKAMP44 upon kinase
activation.
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neurons undergo regulated exocytosis in response to
calcium signals [44], further supporting a role for the
calcium sensing PICK1/PKC complex in this process.
In summary, this study highlights a novel molecular
mechanism that may contribute to PKC association
with AMPARs: via interaction with the PICK1-
Shisa9/CKAMP44 complex. It thereby lays the
groundwork for further investigations into the func-
tional modulation of Shisa9/CKAMP44 and associated
AMPAR protein complexes via PKC signalling cas-
cades that involve PICK1.
Materials and methods
Y2H screen
The Y2H screen (Hybrigenics ULTImate Y2H) was per-
formed by HYBRIGENICS (Paris, France), using the cyto-
plasmic tail of mouse Shisa9/CKAMP44 (171-424 AA),
cloned into pB27 (N-LexA-bait-C, Cter-free) with an adult
mouse brain cDNA library.
Constructs
The CKAMP44 constructs used in this study are based on
mouse SHISA9/CKAMP44 (Uniprot Q9CZN4; 424AA).
All constructs were generated using standard cloning tech-
niques. For full-length FLAG- or MYC-tagged CKAMP44
DNA constructs in the pCMV vector, we cloned the coding
sequence for the FLAG tag (AAs DYKDDDDK) or the
MYC tag (AAs EQKLISEEDL) behind the coding
sequence for the first N-terminal 29 AAs of CKAMP44 (in-
cluding the signal peptide). The constructs containing the
cytoplasmic tail of CKAMP44 express the following AA





The constructs pCMV2A-FLAG-PSD-95 and pCMV2A-
FLAG-SAP102 were described previously [45], and the con-
structs pCMV2A-FLAG-PSD-95-PDZ3-SH3-GK and
pCMV2A-FLAG-PSD-95-PDZ123mut have also been
described [46]; the constructs pCMV2A-FLAG-PSD-95-
PDZ12mut and pCMV2A-FLAG-PSD-95-PDZ3mut were
cloned in similar fashion using standard recombinant DNA
technology. We cloned pCMV3A-MYC-PICK1 (Uniprot
Q9NRD5, human, 415 AA) from human cDNA. A con-
struct expressing FLAG-MAGI1 (mouse, 1432 pcDNA3
flag MAGI1c) was obtained from Addgene (Cambridge,
MA, USA; clone #10714). For the pEGFP-C1-PKCa-WT
construct in our study, we used pHACE-PKCalphaWT
(Addgene clone #21232, human, Uniprot P17252, 672 AA)
as a cloning template, and for the kinase-deficient PKCa
mutant DN (K368R), we used pHACE-PKCalphaDN
(Addgene clone #21235). For generation of virus particles,
FLAG-CKAMP44 was cloned into a lentiviral shuttle vec-
tor under the control of a human synapsin-1 promoter.
Cells/treatment/transfection
COS-7 cells (purchased from ATCC) were maintained in
Dulbecco’s modified Eagle’s medium (DMEM; Lonza, Ver-
viers, Belgium) supplemented with 10% FBS (Sigma-
Aldrich, Taufkirchen, Germany), 2 mM L-glutamine and
penicillin/streptomycin at 37 °C with 5% CO2. Transient
transfections were performed using Lipofectamine 2000
(Thermo Fisher Scientific, Waltham, MA, USA) according
to the manufacturer’s recommendations. COS-7 cells were
treated with 1 lM PMA for 30 min. For the inhibitor
experiment (Fig. 2D), cells were treated for 120 min with
3.5 lM or 7 lM PKC inhibitor GF109203X followed by 60-
min treatment with 0.2 lM PMA. Primary neuronal cul-
tures were generated essentially as described previously
[45], with minor modifications: for primary rat hippocam-
pal neuronal cultures, embryonic E18 Wistar Unilever rats
were used. Following decapitation, hippocampi from 5 to
10 pups were isolated and collected in ice-cold DMEM
(Lonza). Tissue was partially digested in trypsin/EDTA
(Lonza) at 37 °C for 5 min. After stopping the reaction
with 10% FBS (Biochrom, Berlin, Germany) in DMEM
and subsequent washing in DMEM to remove traces of
trypsin, the hippocampal tissue was suspended in neuron
culture medium (Neurobasal A supplemented with B27 and
0.5 mM glutamine) and dissociated mechanically; neurons
were then plated onto glass coverslips coated with a mix-
ture of poly-D-lysine (Sigma) and laminin (Sigma) at a den-
sity of approximately 105 cells per cm2. Cell debris was
removed after healthy neurons adhered to the cover slips,
and neurons were maintained for 2–4 weeks with minimal
perturbation at 37 °C with 5% CO2 in neuron culture med-
ium. Lentiviral particles were prepared by the NeuroCure
Virus Core Facility essentially as described by Lois et al.
[47]. Primary neurons were transduced at DIV10–15 and
analysed after fixation at DIV20–24. PMA treatment of
neurons was with 0.2 lM PMA for 15 min. All animals
used in this study were treated according to German regu-
lations on the use of animals for research purposes and
reported under the permit T0280/10.
Coimmunoprecipitation
Shisa9/CKAMP44 proteins were overexpressed in COS-7
cells together with their candidate interaction partners.
Twenty-four hours post-transfection, cells were harvested in
IP buffer [50 mM Tris pH 7.5, 100 mM NaCl, 0.1 – 1% Tri-
ton-X and Mini Complete Inhibitors (Roche, Basel, Swit-
zerland)] and lysed with 5–10 strokes using a 30-G needle.
Lysates were cleared by two centrifugations for 10 min at
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20 000 g. For IP, lysates were incubated for 3 h at 4 °C
with 2 lg of the respective antibody and transfected pro-
teins were pulled down with protein-G agarose (Roche) for
1 h. Beads were washed three times for 5 min at 4 °C.
Samples were analysed by SDS/PAGE and western blot
(WB).
GST pull-down assays and GST protein
purification
GST-tagged proteins were expressed and purified according
to the manufacturer’s recommendations (GE Healthcare,
Freiburg, Germany). Briefly, BL21 Escherichia coli trans-
formed with the regarding GST protein constructs were
cultured O/N. Expression of GST proteins was induced
with 0.1 mM IPTG, and cells were lysed in TBS containing
1% Triton-X. After lysate clearing at 20 000 g, GST-tagged
proteins were purified using glutathione agarose (Thermo
Fisher Scientific). For GST pull-down assays, the GST-
tagged proteins (bound to the glutathione agarose beads)
were incubated with lysate from adult mouse brains or
from transfected COS-7 cells. For brain lysate pull-down
experiments, adult C57Bl6 mice were sacrificed by cervical
dislocation; whole brains were removed and placed directly
in ice-cold TN buffer [50 mM Tris, pH 7.5, 100 mM NaCl,
and Mini Complete Inhibitors without EDTA (Roche)] and
homogenised. Triton-X was added to the lysate (final con-
centration of 1%) and lysates were kept on ice for 15 min.
TN buffer was added to generate a final Triton-X concen-
tration of 0.5%. Cell debris was removed by high speed
centrifugation (20 000 g). After 3 h of incubation at 4 °C,
the glutathione agarose beads were washed three times and
the bound proteins were analysed by SDS/PAGE and WB.
For the in vitro kinase assay, GST fusion proteins were
purified using glutathione agarose and eluted with 50 mM
glutathione in 200 mM Tris (pH 8). They were desalted
using a Zeba Spin Desalting Column (40 K MWCO;
Thermo Scientific).
In vitro PKCa kinase assay
Purified and desalted GST-CKAMP44 protein was used for
an in vitro PKCa kinase assay (SignalChem, Richmond,
Canada; #P61–18G) according to the manufacturer’s
instructions. Samples were analysed with Phos-tag SDS/
PAGE followed by WB.
Phos-tag SDS/PAGE
Shisa9/CKAMP44 phosphorylation was assessed using the
Phos-tag system (Wako, Neuss, Germany), which facilitates
phosphorylation-dependent retarded protein migration
through a polyacrylamide gel, and subsequent WB. Phos-
tag gel electrophoresis (6–8% polyacrylamide supplemented
with 50 lM Phos-tag) was established using an optimised
protocol with Zn2+ in a bis/tris-buffered neutral pH gel
system either as described previously [48] or according to
the manufacturer’s recommendations. Phos-tag gels were
generally blotted using a wet transfer blotting set-up. As a
control for phosphorylated proteins, the proteins were
dephosphorylated using a thermosensitive alkaline phos-
phatase (FastAP; Thermo Fisher Scientific). The transfected
cells were lysed in 19 FastAP buffer (Thermo Fisher Scien-
tific) containing 1% Triton-X and Mini Complete protease
inhibitors without EDTA (Roche). The lysates were cleared
by centrifugation and proteins were subsequently dephos-
phorylated for 2 h at 37 °C using FastAP.
Immunofluorescence/colocalisation analysis
After 2–4 weeks in culture, differentiated neurons were
fixed in 4% paraformaldehyde (PFA) in phosphate-buf-
fered saline (PBS) for 10 min and immunofluorescence was
performed as described previously [49] according to stan-
dard IF protocols. Briefly, cells were permeabilised in 0.2%
Triton-X in PBS for 5 min, washed in PBS and blocked
with 4% bovine serum albumin (BSA) in PBS for 1 h at
room temperature. They were then incubated overnight
with the primary antibodies in the same solution at 4 °C,
washed with PBS and subsequently incubated with sec-
ondary antibodies in blocking solution. After final washes
in PBS, coverslips were mounted with Fluoromount-G
(Southern Biotech, Birmingham, AL, USA). Images were
acquired with a Leica (Wetzlar, Germany) laser-scanning
confocal microscope (Leica TCS-SP5 II) using a 639 objec-
tive. Dendritic segments of rat hippocampal neurons were
analysed for colocalisation of FLAG-CKAMP44-FL (cyan,
Alexa488) with endogenous PICK1 (magenta, Alexa568).
Regions of interest (ROIs) of merged images were selected
blind to the conditions of the experiments and analysed
with the IMAGEJ (NIH, Bethesda, MD, USA) plugin Puncta
Analyzer as described previously [50]. Number of cells (n)
and number of cultures (N) are stated in the figure legend.
FLAG-CKAMP44-FL puncta (cyan) were analysed for
colocalised PICK1 (magenta). Data are normalised to the
mean of the untreated condition and presented as
mean  SEM (standard error of the mean). Statistics were
calculated using GRAPHPAD Prism 7 (GraphPad Software,
La Jolla, CA, USA) (two-tailed Mann–Whitney U-test for
unpaired data).
Antibodies
Antibodies used in this study include GFP (mouse, Roche
11814460001; goat, Abcam, Cambridge, UK, AB6673, WB
1 : 5000), FLAG (mouse, rabbit, Sigma F1804 and F7425,
respectively, WB 1 : 5000), FLAG-HRP (Sigma A8592,
WB 1 : 5000), MYC (mouse, Clontech, Mountain View,
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Canada, 631206; rabbit, Cell Signaling, Danvers, MA,
USA, 2272S, WB 1 : 5000), MYC-HRP (Abcam AB62928,
WB 1 : 5000), GST (goat, GE Healthcare, 27457701V,
WB 1 : 5000), CKAMP44 (rabbit, custom made by
David’s Biotechnology, Regensburg, Germany, WB
1 : 1000), actin (rabbit, Sigma A2066, WB 1 : 3000),
GAPDH (rabbit, Abcam AB9485, WB 1 : 2000), GluA1
(rabbit, Millipore, Billerica, MA, USA, AB1504, WB
1 : 2000), MAP2 (rabbit, Millipore AB5622; guinea pig,
Synaptic Systems, 188004), PICK1 (rabbit, Abcam
AB3420, WB 1 : 2000), PKCa (mouse, Millipore 05–154,
WB 1 : 2000), PSD-95 (mouse, UC Davis/NIH NeuroMab
Facility, Davis, CA, USA, 75–028, WB 1 : 2000), SAP102
(mouse, UC Davis/NIH NeuroMab Facility 75–058, WB
1 : 2000) and vGlut1 (mouse, UC Davis/NIH NeuroMab
Facility 75–066). For coimmunoprecipitation experiments,
2 lg of the respective antibodies was used. Unspecific
mouse IgGs (mIgG), as required (SantaCruz, Biotechnol-
ogy, Dallas, TX, USA, SC-2025, 2 lg), were used for
negative controls in coimmunoprecipitation studies. All
primary and secondary antibodies were diluted in 5%
milk/PBST for WB or in 4% BSA/PBS for immunofluo-
rescence experiments (1 : 1000). For immunofluorescence
experiments, we used anti-guinea-pig-Alexa405 (Abcam,
ab175678), anti-mouse-Alexa488 and anti-rabbit-Alexa568
or anti-mouse-Alexa568 and anti-rabbit-Alexa488 (Thermo
Fisher Scientific A-21200 and A-11036 or A-11031 and
A-21441, respectively).
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